CD82 restrains pathological Angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells

Circulation

Volumn 130, Issue 17, 2014, Pages 1493-1504

  Wei, Quan ^a,b   Zhang, Feng ^b   Richardson, Mekel M ^b   Roy, Nathan H ^c   Rodgers, William ^b   Liu, Yuechueng ^b   Zhao, Wenyuan ^d   Fu, Chenying ^b   Ding, Yingjun ^e   Huang, Chao ^b   Chen, Yuanjian ^d   Sun, Yao ^d   Ding, Lexi ^b   Hu, Yang ^b   Ma, Jian Xing ^b   Boulton, Michael E ^f   Pasula, Satish ^g   Wren, Jonathan D ^g   Tanaka, Satoshi ^h   Huang, Xiaolin ^e   Thali, Markus ^c   Hämmerling, Günter J ^h   Zhang, Xin A ^b   more..

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e Tongji Hospital   (China)

^f INDIANA UNIVERSITY   (United States)

^g OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cell movement; Endocytosis; Membrane microdomains; Neovascularization; Pathological

Indexed keywords

ALPHA6 INTEGRIN; BETA1 INTEGRIN; CD51 ANTIGEN; CD82 ANTIGEN; CELL ADHESION MOLECULE; CLATHRIN; FIBRONECTIN; GANGLIOSIDE; HEMOGLOBIN; HERMES ANTIGEN; HYALURONIC ACID; LAMININ; LIPID; MATRIGEL; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; TALIN; TETRASPANIN; VASCULOTROPIN RECEPTOR 2; VINCULIN; CD44 PROTEIN, MOUSE; CD82 ANTIGEN, MOUSE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CELL ADHESION; CELL AGGREGATION; CELL FUNCTION; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CELL MOTION; CELL PROLIFERATION; CELL STIMULATION; CELL SURFACE; CLUSTER ANALYSIS; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; EX VIVO STUDY; FOCAL ADHESION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPID RAFT; MOLECULAR INTERACTION; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RETINA BLOOD VESSEL; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL LINE; CYTOSKELETON; GENETICS; KNOCKOUT MOUSE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; ANTIGENS, CD44; ANTIGENS, CD82; CELL ADHESION MOLECULES; CELL LINE; CELL MOVEMENT; CYTOSKELETON; ENDOCYTOSIS; ENDOTHELIAL CELLS; GANGLIOSIDES; MEMBRANE MICRODOMAINS; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 84922010313     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.011096     Document Type: Article

References (42)

1. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 1997;277:48-50.
2. Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer. 2008;8:604-617.
3. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9:653-660.
4. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signaling: in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359-371.
5. Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res. 2005;97:1093-1107.
6. Hodivala-Dilke K. Alphavbeta3 integrin and angiogenesis: a moody integrin in a changing environment. Curr Opin Cell Biol. 2008;20:514-519.
7. Somanath PR, Malinin NL, Byzova TV. Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis. 2009;12:177-185.
8. Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M, Sánchez-Madrid F. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol. 2009;19:434-446.
9. Richardson MM, Jennings LK, Zhang XA. Tetraspanins and tumor progression. Clin Exp Metastasis. 2011;28:261-270.
10. Odintsova E, Butters TD, Monti E, Sprong H, Van Meer G, Berditchevski F. Gangliosides play an important role in the organization of CD82-enriched microdomains. Biochem J. 2006;400:315-325.
11. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem. 2007;282:8123-8133.
12. Xu C, Zhang YH, Thangavel M, Richardson MM, Liu L, Zhou B, Zheng Y, Ostrom RS, Zhang XA. CD82 endocytosis and cholesteroldependent reorganization of tetraspanin webs and lipid rafts. FASEB J. 2009;23:3273-3288.
13. Custer MC, Risinger JI, Hoover S, Simpson RM, Patterson T, Barrett JC. Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor. Prostate. 2006;66:567-577.
14. Hashimoto A, Tarner IH, Bohle RM, Gaumann A, Manetti M, Distler O, Steinmeyer J, Ulfgren AK, Schulz A, Gay S, Müller-Ladner U, Neumann E. Analysis of vascular gene expression in arthritic synovium by lasermediated microdissection. Arthritis Rheum. 2007;56:1094-1105.
15. Nagao K, Oka K. HIF-2 directly activates CD82 gene expression in endothelial cells. Biochem Biophys Res Commun. 2011;407:260-265.
16. Roy NH, Chan J, Lambelé M, Thali M. Clustering and mobility of HIV-1 Env at viral assembly sites predict its propensity to induce cell-cell fusion. J Virol. 2013;87:7516-7525.
17. Schwenk F, Baron U, Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-fanked gene segments including deletion in germ cells. Nucleic Acids Res. 1995;23:5080-5081.
18. Zhang XA, Huang C. Tetraspanins and cell membrane tubular structures. Cell Mol Life Sci. 2012;69:2843-2852.
19. Cao G, Savani RC, Fehrenbach M, Lyons C, Zhang L, Coukos G, Delisser HM. Involvement of endothelial CD44 during in vivo angiogenesis. Am J Pathol. 2006;169:325-336.
20. Golshani R, Lopez L, Estrella V, Kramer M, Iida N, Lokeshwar VB. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Res. 2008;68:483-491.
21. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, De Lisser HM. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem. 2001;276:36770-36778.
22. Tremmel M, Matzke A, Albrecht I, Laib AM, Olaku V, Ballmer-Hofer K, Christofori G, Héroult M, Augustin HG, Ponta H, Orian-Rousseau V. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. Blood. 2009;114:5236-5244.
23. Howes MT, Kirkham M, Riches J, Cortese K, Walser PJ, Simpson F, Hill MM, Jones A, Lundmark R, Lindsay MR, Hernandez-Deviez DJ, Hadzic G, McCluskey A, Bashir R, Liu L, Pilch P, McMahon H, Robinson PJ, Hancock JF, Mayor S, Parton RG. Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J Cell Biol. 2010;190:675-691.
24. Tammi R, Rilla K, Pienimaki JP, MacCallum DK, Hogg M, Luukkonen M, Hascall VC, Tammi M. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem. 2001;276:35111-35122.
25. Kiskowski MA, Hancock JF, Kenworthy AK. On the use of Ripley's K-function and its derivatives to analyze domain size. Biophys J. 2009;97:1095-1103.
26. Chichili GR, Cail RC, Rodgers W. Cytoskeletal modulation of lipid interactions regulates Lck kinase activity. J Biol Chem. 2012;287:24186-24194.
27. Jameson SA, Natarajan A, Cool J, De Falco T, Maatouk DM, Mork L, Munger SC, Capel B. Temporal transcriptional profiling of somatic and germ cells reveals biased lineage priming of sexual fate in the fetal mouse gonad. PLoS Genet. 2012;8:e1002575.
28. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003;9:685-693.
29. Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol. 2007;2:251-275.
30. Estrach S, Cailleteau L, Franco CA, Gerhardt H, Stefani C, Lemichez E, Gagnoux-Palacios L, Meneguzzi G, Mettouchi A. Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells. Circ Res. 2011;109:172-182.
31. Larrieu-Lahargue F, Welm AL, Thomas KR, Li DY. Netrin-4 activates endothelial integrin {alpha}6{beta}1. Circ Res. 2011;109:770-774.
32. Zöller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer. 2011;11:254-267.
33. Bourguignon LY, Zhu H, Shao L, Chen YW. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic aciddependent ovarian tumor cell migration. J Biol Chem. 2001;276:7327-7336.
34. Oliferenko S, Paiha K, Harder T, Gerke V, Schwärzler C, Schwarz H, Beug H, Günthert U, Huber LA. Analysis of CD44-containing lipid rafts: recruitment of annexin II and stabilization by the actin cytoskeleton. J Cell Biol. 1999;146:843-854.
35. Kumar P, Amin MA, Harlow LA, Polverini PJ, Koch AE. Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis. Blood. 2003;101:3960-3968.
36. Griffioen AW, Coenen MJ, Damen CA, Hellwig SM, Van Weering DH, Vooys W, Blijham GH, Groenewegen G. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood. 1997;90:1150-1159.
37. Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C, Delpech B, Lu H. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer. 1996;66:664-668.
38. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14:163-176.
39. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol. 2005;168:477-488.
40. Sabharanjak S, Sharma P, Parton RG, Mayor S. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrinindependent pinocytic pathway. Dev Cell. 2002;2:411-423.
41. Lingwood D, Ries J, Schwille P, Simons K. Plasma membranes are poised for activation of raft phase coalescence at physiological temperature. Proc Natl Acad Sci U S A. 2008;105:10005-10010.
42. Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem. 2005;280:35545-35553.